Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for IgG4-related sclerosing cholangitis has been reported in the published literature.
No clinical trials have been registered for IgG4-related sclerosing cholangitis.
39 publications have been identified in PubMed for IgG4-related sclerosing cholangitis. Research spans Case Report / Case Series (49%), Review / Meta-Analysis (24%), and Other (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 18 | 49% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 1:01 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about IgG4-related sclerosing cholangitis
9 |
24% |
Other research | 4 | 11% |
Testing and diagnosis research | 4 | 11% |
Disease patterns and progression | 2 | 5% |
Naitoh I (2026). [PMID: 41800696](https://pubmed.ncbi.nlm.nih.gov/41800696/). *J Hepatobiliary Pancreat Sci*. [Other]
Yoneyama S (2026). [PMID: 41526216](https://pubmed.ncbi.nlm.nih.gov/41526216/). *Nihon Shokakibyo Gakkai Zasshi*. [Case Report / Case Series]
Liu YA (2026). [PMID: 42004961](https://pubmed.ncbi.nlm.nih.gov/42004961/). *Front Immunol*. [Case Report / Case Series]
Hong G (2026). [PMID: 41402032](https://pubmed.ncbi.nlm.nih.gov/41402032/). *J Liver Cancer*. [Case Report / Case Series]
Yang Y (2026). [PMID: 42079574](https://pubmed.ncbi.nlm.nih.gov/42079574/). *Front Immunol*. [Review / Meta-Analysis]
Liu Z (2026). [PMID: 42112333](https://pubmed.ncbi.nlm.nih.gov/42112333/). *Front Immunol*. [Case Report / Case Series]
Ren X (2026). [PMID: 41728618](https://pubmed.ncbi.nlm.nih.gov/41728618/). *Front Med (Lausanne)*. [Review / Meta-Analysis]
Wang MC (2026). [PMID: 41989037](https://pubmed.ncbi.nlm.nih.gov/41989037/). *Am J Gastroenterol*. [Diagnostic / Biomarker]
Wan Y (2026). [PMID: 42136643](https://pubmed.ncbi.nlm.nih.gov/42136643/). *Front Immunol*. [Epidemiology / Natural History]
Morimoto K (2026). [PMID: 40889100](https://pubmed.ncbi.nlm.nih.gov/40889100/). *Clin J Gastroenterol*. [Case Report / Case Series]
AI-curated news mentioning IgG4-related sclerosing cholangitis
Updated Jul 23, 2026
A recent study explores the correlation between autoimmune pancreatitis and IgG4-related cholangitis, highlighting the importance of radiologic and serologic assessments. This research contributes to the understanding of these autoimmune conditions and their interrelation.